Newsroom


Read Now Button
2024 Spring Newsletter
Catch up on the latest happenings in our spring newsletter.

Newsletter logo
2024 Winter Newsletter

Explore the most recent updates in the 2024 Winter Newsletter.


AstraZeneca Logo
WAINUA (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis

December 21, 2023

US FDA approval based on NEURO-TTRansform Phase III results showing WAINUA demonstrated consistent and sustained benefit improving neuropathy impairment and quality of life

Additional regulatory reviews underway in rest of world


Read now button
2023 Fall Newsletter
Be sure to catch up on the latest happenings in our fall newsletter.